Choroideremia Research Foundation
Dedicated to CHM research, patient education and advocacy.
CRF has funded approximately $5 million in research on the causes and potential therapies for choroideremia since 2000.
The organization hosts regular conferences for patients and families as well as scientific symposia for researchers and clinicians. It also offers one-day regional meetings several times a year around the world. Webinars and interactive online chats are offered (and recorded) several times monthly on topics such as emotional support, research, assistive technology, clinical trials and genetic testing.
In August 2021, the CRF launched the International Choroideremia Research Network (ICRN), a global alliance of vision professionals seeking to accelerate scientific knowledge about CHM. The network is now composed of over 130 multi-disciplinary vision professionals from 25 countries.
CRF’s research projects have included establishment of a CHM mouse model, creating induced pluripotent stem cell (iPSC) models, formation of a human CHM cell biobank, and support of several pre-clinical gene therapy research studies which ultimately led to launch of three clinical trials.
Brands: International Choroideremia Research Network (ICRN), CRF, Team CHM